News & Updates

Show Multimedia Only
High-intensity training eases anxiety, stress in prostate cancer

High-intensity training eases anxiety, stress in prostate cancer

17 Apr 2022

A supervised high-intensity interval training (HIIT) program for 12 weeks leads to improvements in prostate cancer-specific anxiety, fear of cancer progression, hormone symptoms, stress, fatigue, and self-esteem in men on active surveillance, reports a study.

High-intensity training eases anxiety, stress in prostate cancer

17 Apr 2022
Noninvasive nerve stimulation device eases migraine

Noninvasive nerve stimulation device eases migraine

17 Apr 2022
Secondary primary malignancies worsen multiple myeloma survival

Secondary primary malignancies worsen multiple myeloma survival

16 Apr 2022

While survival among multiple myeloma patients has been improving over time, the development of secondary primary malignancies seems to offset this effect by increasing the risk of mortality, a recent study has found.

Secondary primary malignancies worsen multiple myeloma survival

16 Apr 2022
Cardiometabolic risk tied to NAFLD

Cardiometabolic risk tied to NAFLD

16 Apr 2022

Cardiometabolic risk factors increase the risk of nonalcoholic fatty liver disease (NAFLD), though such interactions seem to vary between lean and nonlean individuals, a recent study has found.

Cardiometabolic risk tied to NAFLD

16 Apr 2022
Eating fruits, exercising curb risk of adverse events in type 2 diabetes patients

Eating fruits, exercising curb risk of adverse events in type 2 diabetes patients

16 Apr 2022

In patients with type 2 diabetes, consuming fruits and engaging in physical activity can reduce the risk of all-cause, cardiovascular disease, and stroke mortality, a study reports.

Eating fruits, exercising curb risk of adverse events in type 2 diabetes patients

16 Apr 2022
Obesity med cessation more likely after RYGB than sleeve gastrectomy

Obesity med cessation more likely after RYGB than sleeve gastrectomy

15 Apr 2022 byRoshini Claire Anthony

Patients who are on obesity-related medications before undergoing bariatric surgery may be more likely to discontinue their medications and less likely to restart them after undergoing Roux-en-Y gastric bypass (RYGB) than laparoscopic sleeve gastrectomy (LSG), a recent study has shown.

Obesity med cessation more likely after RYGB than sleeve gastrectomy

15 Apr 2022